TORL Targets Hot ADC Space with Oversubscribed $158M Series B-2 4/10/2024
Birth Control Market Evolves as OTC Opill Hits US Stores 4/10/2024
Can $12 Billion Jumpstart Women’s Health? 4/10/2024
Alphabet Soup: AACR and ACC Dominate Headlines This Week 4/10/2024
YS Biopharma’s Rabies Vaccine Outperforms Commercial Competitor in Phase III Trial 4/10/2024
AACR: Study Suggests Accelerated Approval Doesn’t Always Lead to Clinical Benefit 4/10/2024
7 Billion-Dollar Oncology M&As from Q1 4/10/2024
The IRA Is Already Curtailing Small Molecule Drug Development. Here’s How to Reverse That. 4/10/2024
Poor Customer Data Management Costs Pharma Companies Money: Report 4/10/2024
AACR 2024: What Cancer Researchers Are Talking About 4/10/2024
PBMs ‘Wield Enormous Power’ Over Patient Access to Affordable Drugs: FTC 7/9/2024
Lilly’s Mounjaro Helps Patients Lose More Weight Than Novo’s Ozempic: Study 7/9/2024
House Speaker Plans to Vote, Pass BIOSECURE Act into Law This Year 7/9/2024
Pfizer CSO Mikael Dolsten to Step Down After 15 Years Driving R&D 7/9/2024
FDA CBER Director Dr. Peter Marks Discusses Industry Growth, Collaboration and Communication 7/9/2024
US Government Files Appeal in High-Stakes HIV PrEP Patent Battle Against Gilead 7/9/2024
What Does Wegovy’s Launch in China Mean as Biosimilar Competition Emerges? 7/9/2024
Roche Reintroduces Wet AMD Eye Implant Nearly Two Years After Voluntary Recall 7/9/2024
UniQure Wins First FDA RMAT in Huntington’s Disease After Strong Phase I/II Data 7/9/2024
Novo Inks $600M Deal with Metaphore to Develop Next-Gen Obesity Drugs 5/9/2024